Claro Advisors LLC Increases Stake in Intuitive Surgical, Inc.

Claro Advisors LLC has significantly increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.8% during the third quarter of the year. According to the latest disclosure submitted to the Securities and Exchange Commission (SEC), Claro Advisors now owns 1,398 shares of this medical equipment provider after acquiring an additional 495 shares in the recent quarter. The value of Claro Advisors' investments in Intuitive Surgical reached $687,000 at the conclusion of the last quarter.

Other institutional investors have also adjusted their positions in Intuitive Surgical. For instance, Ullmann Wealth Partners Group LLC raised its stake by 1.6%, now holding 1,329 shares valued at approximately $653,000 after purchasing 21 more shares. Similarly, One Wealth Management Investment & Advisory Services LLC expanded its investment by 3.4%, now owning 697 shares with a total value of about $310,000 post its acquisition of 23 additional shares. Meanwhile, Daymark Wealth Partners LLC grew its position by a slight 0.3%, ending up with 7,027 shares valued at around $3,452,000 after acquiring 24 more shares.

Indiana Trust & Investment Management CO has also increased its holdings by 5.3%, with a current total of 500 shares worth approximately $222,000 after purchasing an additional 25 shares. Additionally, Hoxton Planning & Management LLC raised its stake in the company by 4.9% with a total of 534 shares valued at $238,000 following a purchase of 25 shares. Overall, institutional investors and hedge funds collectively own 83.64% of Intuitive Surgical’s stock.

Insider Activity at Intuitive Surgical

In other developments, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock on September 12th. The shares were sold at an average price of $491.91, amounting to a total value of $1,040,389.65. Following this sale, Brosius retains ownership of 295 shares, estimated to be worth about $145,113.45, marking no change in his reported ownership percentage. This transaction was detailed in a filing with the SEC. Furthermore, EVP Robert Desantis sold 1,413 shares on July 26th at an average price of $438.60, generating $619,741.80. Post-transaction, he holds 5,506 shares valued at $2,414,931.60, also reflecting no change in his ownership percentage. In total, company insiders have sold 53,120 shares amounting to $25,528,753 over the last three months, with insiders owning 0.90% of the stock.

Intuitive Surgical Stock Performance

As of the latest trading session, Intuitive Surgical stock opened at $521.15. The company has experienced a one-year low of $254.85 and a high of $523.34. Currently, the 50-day and 200-day simple moving averages are $483.85 and $438.17, respectively. The company's market capitalization is approximately $184.85 billion, with a price-to-earnings (P/E) ratio of 94.07 and a P/E to growth (P/E/G) ratio of 5.40. The stock also exhibits a beta of 1.39, indicating its volatility in comparison to the market.

Intuitive Surgical recently reported its quarterly earnings on July 18th, revealing earnings per share (EPS) of $1.78, surpassing analysts’ expectations of $1.54 by $0.24. The company achieved a return on equity of 13.04% and a net margin of 27.65%. Revenue for the quarter totaled $2.01 billion, exceeding analysts' expectations of $1.97 billion, and exhibited a 14.5% increase compared to the same quarter the previous year. Analysts project that the company will report an EPS of 5.22 for the current fiscal year.

Analyst Ratings Changes

Recent evaluations by various brokerages indicate positive sentiment towards Intuitive Surgical. Truist Financial upgraded their target price from $520.00 to $570.00 with a “buy” rating. The Goldman Sachs Group set a target price of $604.00, while Raymond James lifted their target from $500.00 to $540.00, maintaining an “outperform” stance. Moreover, Leerink Partners raised their price target from $489.00 to $502.00. Royal Bank of Canada also increased its target from $525.00 to $555.00, maintaining an “outperform” rating. Currently, the stock holds a consensus rating of “Moderate Buy” from analysts, with one sell rating, five hold ratings, and fourteen buy ratings, and has an average target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc. is engaged in developing, manufacturing, and marketing medical devices designed to improve the quality of and access to minimally invasive surgical care for healthcare providers both in the U.S. and internationally. Its flagship product is the da Vinci Surgical System, which facilitates complex surgeries through minimally invasive techniques, alongside the Ion endoluminal system that allows for minimally invasive biopsies in the lung.

investment, stocks, insider